ORS-22

Overview

ORS-22 is an immunomodulator with a K d value of 9.2 nM for human LILRB4 . ORS-22 binds directly to the extracellular domain of LILRB4, reverses immunosuppression, restores cytotoxic T cell function, recovers cytokine production, and reduces tumor cell viability. ORS-22 can be used in research related to colorectal cancer and acute myeloid leukemia.

Application

Products | Products > Disease Areas > Blood Disease | Products > Disease Areas > Acute Myeloid Leukemia | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > LILRB

Product Information

• Catalog No.: HY-184688
• CAS No.: 1311612-43-7
• Molecular Formula: C16H18N6OS
• Molecular Weight: 342.42
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source